Avantor, Inc. reported $6.55B of revenue over the trailing twelve months, −2.0% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $6.55B (to Q1 2026). Net income: −$551M, trailing twelve months to Q1 2026. Free cash flow: $439M, trailing twelve months to Q1 2026. Operating margin: −4.6%, trailing twelve months to Q1 2026.

AVTRAvantor, Inc.

Healthcare

$15.67+25% 1Y

$15.67

$7.4152 weeks$15.85

AVTR as reported

Avantor, Inc. reported $6.55B of revenue over the trailing twelve months, −2.0% on the year before. 11 reported series are charted on this page, each one as filed.

$6.55B

Revenue, trailing twelve months · to Q1 2026 · −2.0% against the twelve months before

Net income: −$551M
Net income · −177% year on year · trailing twelve months to Q1 2026
Free cash flow: $439M
Free cash flow · −34% year on year · trailing twelve months to Q1 2026
Operating margin: −4.6%
Operating margin · trailing twelve months to Q1 2026

Details›

Every series Ryufin has for AVTR, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$6.55B	−2.0%	Q1 2026
Net income	−$551M	−177%	Q1 2026
EPS	−$0.81	−178%	Q1 2026
Gross margin	32%	n/a	Q1 2026
Operating margin	−4.6%	n/a	Q1 2026
Net margin	−8.5%	n/a	Q1 2026
ROE	−2.5%	n/a	Q1 2026
ROA	−1.1%	n/a	Q1 2026
ROIC	1.4%	n/a	Q1 2026
Free cash flow	$439M	−34%	Q1 2026
P/E	26.7	n/a	Q2 2025

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.